Sudeep Das

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 102 citations · Full text

Medicine, Oncology, Chemotherapy +11

Financial toxicities in patients receiving systemic therapy for brain tumors: A cross-sectional study

VijayM Patil, Devanshi Kalra, Nandini Menon et al. · Cancer Research Statistics and Treatment · 2020 · 33 citations · Full text

Medicine, Oncology, Health Care Finance +11

Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care center in North India

Somnath Roy, TanmoyKumar Mandal, Sudeep Das et al. · Cancer Research Statistics and Treatment · 2020 · 22 citations · Full text

Medicine, Oncology, Cancer Epidemiology +7

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer

Vanita Noronha, Vijay Patil, Vijayalakshmi Mathrudev et al. · European Journal of Cancer · 2024 · 15 citations

Medicine, Oncology, Pharmacology +5

Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit

Bal Krishna Mishra, Akhil Kapoor, Anuj Gupta et al. · ecancermedicalscience · 2022 · 12 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +15